Correlation Between Mallinckrodt Plc and China SXT
Can any of the company-specific risk be diversified away by investing in both Mallinckrodt Plc and China SXT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mallinckrodt Plc and China SXT into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mallinckrodt Plc and China SXT Pharmaceuticals, you can compare the effects of market volatilities on Mallinckrodt Plc and China SXT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mallinckrodt Plc with a short position of China SXT. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mallinckrodt Plc and China SXT.
Diversification Opportunities for Mallinckrodt Plc and China SXT
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mallinckrodt and China is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Mallinckrodt Plc and China SXT Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China SXT Pharmaceuticals and Mallinckrodt Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mallinckrodt Plc are associated (or correlated) with China SXT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China SXT Pharmaceuticals has no effect on the direction of Mallinckrodt Plc i.e., Mallinckrodt Plc and China SXT go up and down completely randomly.
Pair Corralation between Mallinckrodt Plc and China SXT
If you would invest 46.00 in Mallinckrodt Plc on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Mallinckrodt Plc or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Mallinckrodt Plc vs. China SXT Pharmaceuticals
Performance |
Timeline |
Mallinckrodt Plc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
China SXT Pharmaceuticals |
Mallinckrodt Plc and China SXT Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mallinckrodt Plc and China SXT
The main advantage of trading using opposite Mallinckrodt Plc and China SXT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mallinckrodt Plc position performs unexpectedly, China SXT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China SXT will offset losses from the drop in China SXT's long position.Mallinckrodt Plc vs. Lifecore Biomedical | Mallinckrodt Plc vs. Shuttle Pharmaceuticals | Mallinckrodt Plc vs. Organogenesis Holdings | Mallinckrodt Plc vs. Journey Medical Corp |
China SXT vs. Akanda Corp | China SXT vs. Petros Pharmaceuticals | China SXT vs. GelStat Corp | China SXT vs. Shuttle Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |